ARKG.US ARK Genomic Revolution ETF

ETF Healthcare Equity ARK ETF Trust USA Stocks
- USD
No recent price
Total assets
1.99B
Expense ratio
0.71%
Dividend yield
-
1-year return
+54.78%
Holdings
32
Since
2014

Fund data as reported by the issuer, updated Nov 14, 2026. Total assets are in the fund's base currency.

What does ARKG.US invest in?

  • Mostly US stocks (87.5%)
  • Largest sector: Healthcare (100.0%)
  • Largest region: North America (91.3%)
  • Top 3 holdings: 26.6% of the fund

Asset allocation

  • US stocks 87.5%
  • Non-US stocks 8.1%
  • Cash 0.2%

Top holdings

All holdings, sectors and regions

ARK Genomic Revolution ETF performance

Sharpe ratio 0.74
This year
+51.00%
1 year
+54.78%
3 years
+22.67%
5 years
-9.42%

Volatility 42.2% over 1 year and 39.1% over 3 years. High: expect large swings.

Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers

ARKG.US price

Prices on the chart can differ slightly from the closing prices StockSummer shows.

About ARK Genomic Revolution ETF

The fund is an actively-managed exchange-traded fund (ETF) that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution (Genomics Revolution Companies). It is non-diversified.

Full fund profile